IQVIA’s RADDS group offers a “molecule‑to‑market” service that assigns dedicated program managers and draws on regulatory intelligence and outsourced experts to guide development. The program covers strategy and gap analyses, CMC and clinical submissions, labelling, regulatory roadmaps and lifecycle management. This integrated approach speeds development and reduces risk by coordinating all regulatory and drug‑development activities.

Join for free to read